Viatris Inc. (VTRS)
$17.64+1.15%Close
BUYBULL · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $20.5B
- Beta
- 0.88
- Div yield
- 2.74%
- P/E (TTM)
- -48.72
- Short % float
- 3.66%
- Days to cover
- 4.2
- SI change
- +3.1%
- 1W
- +0.23%
- 1M
- +7.69%
- vs SPY 1W
- -0.93%
- vs SPY 1M
- +4.70%
Industry peers
FMP comparable companies · ranked by market cap
- IPCALAB.NSIpca Laboratories Limited$485.9B$1915.40
- TEVABUYTeva Pharmaceutical Industries Limited$47.9BBULLQ 13$41.10+4.71%
- HLNSELLHaleon plc$41.0BRECOVERYQ 18$9.32+0.65%
- RDYBUYDr. Reddy's Laboratories Limited$10.4BRECOVERYQ 16$12.48+2.30%
- ALKSSELLAlkermes plc$6.8BRECOVERYQ 6$40.61+1.25%
- AMRXBUYAmneal Pharmaceuticals, Inc.$6.4BBULLQ 15$19.91+1.32%
- OGNBUYOrganon & Co.$3.6BBULLQ -2$13.81+0.44%
- BHCSELLBausch Health Companies Inc.$2.3BRECOVERYQ 2$6.04+0.00%
- ANIPSELLANI Pharmaceuticals, Inc.$1.7BRECOVERYQ 9$73.89+2.65%
- AMPHBUYAmphastar Pharmaceuticals, Inc.$1.2BRECOVERYQ 9$26.62+3.14%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VTRS?
- LOPJLB’s latest quantitative signal on Viatris Inc. (VTRS) is BUY in a BULL regime. Signals are updated daily.
- What market regime is VTRS in?
- Viatris Inc. (VTRS) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Viatris Inc. (VTRS) do?
- Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimi…